Business Trends– category –
-
Dynamic Perfusion Culture Revolutionizes Monoclonal Antibody Manufacturing: Maximizing Product Quality and Yield, Driving Continuous Biomanufacturing
Bioprocess Online USA Overview While fed-batch remains standard for mAb production, dynamic perfusion culture offers compelling opportunities to boost product quality, yield, and facility utilization by optimizing cell growth and metabol... -
CDMOs Overcome Multispecific Manufacturing Challenges with Continuous Bioprocessing and Catalent’s GPEx® Lightning Platform
BioSpace Unknown Overview Contract Development and Manufacturing Organizations (CDMOs) confront complex challenges in cell line development, analytical characterization, and downstream purification for multispecific molecules. To overcom... -
Estonia’s ÄIO and TFTAK Kick Off €1.94M ‘DigiFoundry 2.0’ Project to Revolutionize Microbial Oil Production with Digital Biomanufacturing
World Bio Market Insights Estonia Overview Estonian biotech firm ÄIO and research institution TFTAK have launched 'DigiFoundry 2.0,' a three-year, €1.94 million initiative aimed at optimizing microbial oil production for enhanced cost co... -
Continuous Upstream Bioprocessing Gains Traction, WuXi Biologics Pioneers Fully Automated Perfusion Platform for Enhanced Productivity
Pharma Manufacturing USA Overview Continuous upstream bioprocessing, especially perfusion culture, is significantly enhancing productivity and consistency in biomanufacturing. CDMOs are increasing investments in continuous bioprocessing ... -
TScan Therapeutics Pivots to In Vivo TCR-T Therapy, Halting Allogeneic Cell Program TSC-101 Amidst Manufacturing Challenges
FirstWord Pharma USA Overview TScan Therapeutics announced a strategic pivot, discontinuing its lead allogeneic cell therapy program, TSC-101, and shifting focus to preclinical in vivo TCR-T candidates for solid tumors, citing funding co... -
Evonik Invests $108M in Vancouver GMP Facility, Significantly Expanding Lipid-Based Drug Delivery Manufacturing Capacity
Contract Pharma USA Overview Evonik has announced a significant investment of $108 million into its GMP formulation manufacturing facility in Vancouver, Canada, dedicated to lipid-based drug delivery. This substantial capital injection a... -
Retinal Diseases Emerge as Key Proving Ground for Next-Gen iPSC Regenerative Therapies, BioProcess International Reports
BioProcess International USA Overview BioProcess International reports that iPSC-derived regenerative therapies are increasingly seen as the primary proving ground for next-generation treatments in retinal diseases. iPSCs enable scalable... -
REPROCELL Accelerates Clinical-Grade iPSC Manufacturing Scale-Up with StemRNA™ Clinical Platform and AI-Driven StemEdit
REPROCELL Japan Overview REPROCELL is significantly accelerating the scale-up of clinical-grade induced pluripotent stem cell (iPSC) manufacturing by leveraging its proprietary StemRNA™ Clinical iPSC platform and AI-driven StemEdit gene-... -
thyssenkrupp nucera Reportedly Halts Electrolyzer Mass Production Plans in Arnstadt, Germany, Impacting Factory Prospects
Blackout News Germany Overview German electrolyzer manufacturer thyssenkrupp nucera has reportedly suspended its large-scale electrolyzer mass production plans in Arnstadt, Germany. This decision impacts the planned factory construction ... -
Teragen Energy Raises $6 Million in Pre-Seed Funding for Fuel Cell Technology to Power Data Centers
Dealroom.co USA Overview Teragen Energy has secured $6 million in pre-seed funding to develop innovative fuel cell technology specifically designed for data center power supply. This capital will accelerate the company's technology devel...
